BJDX
Bluejay Diagnostics Inc
NASDAQ: BJDX · HEALTHCARE · MEDICAL DEVICES
$1.88
+4.44% today
Updated 2026-04-30
Market cap
$1.96M
P/E ratio
—
P/S ratio
54.99x
EPS (TTM)
$-15.25
Dividend yield
—
52W range
$2 – $17
Volume
0.2M
Bluejay Diagnostics Inc (BJDX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $916518.00 | $1.52M | $21.02M | $13.52M | $4.87M | $6.66M |
| Cash & equivalents | $96011.00 | $912361.00 | $19.05M | $10.11M | $2.21M | $4.30M |
| Current assets | $300341.00 | $1.06M | $20.66M | $11.79M | $3.22M | $4.90M |
| Total liabilities | $3.85M | $5.72M | $637162.00 | $1.98M | $1.97M | $927924.00 |
| Current liabilities | $576538.00 | $1.85M | $637162.00 | $1.64M | $1.77M | $810368.00 |
| Long-term debt | $804288.00 | — | — | — | — | — |
| Shareholder equity | $-2.93M | $-4.21M | $20.38M | $11.54M | $2.89M | $5.73M |
| Retained earnings | $-2.93M | $-4.21M | $-7.69M | $-17.00M | $-26.95M | $-34.67M |
| Accounts receivable | $645.00 | $7965.00 | — | — | $41269.00 | $14564.00 |
| Inventory | $123508.00 | $84762.00 | $0.00 | — | — | — |
| Goodwill | — | — | — | — | — | — |